Scrip
Face-to-Face: Trophos looks to nourish ALS market with olesoxime
18 January 2010
Simon Varcoe
Please Login to read the full article.
18 January 2010
Simon Varcoe
At last year's Bio-Europe Spring conference,
Trophos's CEO Dr
Damian Marron told
Scrip that the French company had high hopes for its lead product TRO19622 (olesoxime) in amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy. Nine months later he spoke to Simon Varcoe about how...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
